Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	kinase binding	ABL1 MYOM1 PDGFRB CASP1 CARD16 PPEF2 ITGAX GDNF LAX1 NOD2 THY1 PTPRF ANKRA2 NBEAL2 IQSEC1 TJP2 TRPV4 FCRL5 MAPK8IP2	1.66e-05	969	130	19	GO:0019900
GeneOntologyMolecularFunction	tyrosinase activity	TYR TYRP1	4.21e-05	2	130	2	GO:0004503
GeneOntologyMolecularFunction	CARD domain binding	CASP1 CARD16 NOD2	1.72e-04	17	130	3	GO:0050700
GeneOntologyMolecularFunction	protein kinase binding	ABL1 PDGFRB PPEF2 ITGAX GDNF LAX1 NOD2 THY1 PTPRF ANKRA2 NBEAL2 IQSEC1 TJP2 TRPV4 FCRL5 MAPK8IP2	1.78e-04	873	130	16	GO:0019901
GeneOntologyMolecularFunction	phosphatidylserine flippase activity	ATP8B1 ATP11C	4.15e-04	5	130	2	GO:0140346
GeneOntologyMolecularFunction	nucleoside-triphosphatase regulator activity	DOCK3 RAPGEF6 RAPGEF1 THY1 ARHGAP31 GNB5 IQSEC1 NPRL3 DEPDC5 RIC8A RP2	4.87e-04	507	130	11	GO:0060589
GeneOntologyMolecularFunction	GTPase regulator activity	DOCK3 RAPGEF6 RAPGEF1 THY1 ARHGAP31 GNB5 IQSEC1 NPRL3 DEPDC5 RIC8A RP2	4.87e-04	507	130	11	GO:0030695
GeneOntologyMolecularFunction	GTPase activator activity	DOCK3 THY1 ARHGAP31 GNB5 NPRL3 DEPDC5 RIC8A RP2	4.91e-04	279	130	8	GO:0005096
GeneOntologyMolecularFunction	aminophospholipid flippase activity	ATP8B1 ATP11C	8.65e-04	7	130	2	GO:0015247
GeneOntologyMolecularFunction	oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen	TYR TYRP1	8.65e-04	7	130	2	GO:0016716
GeneOntologyBiologicalProcess	cell-cell adhesion	ROBO4 ABL1 KIF26B RAPGEF1 CD46 VSIG10 ITGAX ZBTB1 SVEP1 LAX1 CFHR4 NOD2 NPTN THY1 PTPRF F11R HMCN1 ZNF608 TJP2 TRPV4 RIC8A GPNMB	1.67e-06	1077	134	22	GO:0098609
GeneOntologyBiologicalProcess	neuron development	ADCY10 ROBO4 NPR2 SETX ABL1 UBE4B SCYL3 RAPGEF1 ATP8B1 GDNF CFHR4 NEDD4 NPTN NSMF THY1 PTPRF PLPPR4 PLXNC1 TRPV2 IQSEC1 SECISBP2 TRPV4 FGFR2 MAPK8IP2	2.25e-05	1463	134	24	GO:0048666
GeneOntologyBiologicalProcess	establishment of endothelial barrier	ROBO4 RAPGEF6 RAPGEF1 F11R TJP2	3.73e-05	58	134	5	GO:0061028
GeneOntologyCellularComponent	cell surface	IL11RA ROBO4 PDGFRB TRGV1 TRGV4 CD46 CUBN ITGAX CRLF2 CFHR4 NOD2 FZD9 NPTN THY1 PLPPR4 TRPV2 TJP2 TRPV4 FGFR2 FCRL5	3.04e-05	1111	135	20	GO:0009986
GeneOntologyCellularComponent	AIM2 inflammasome complex	CASP1 CARD16	2.46e-04	4	135	2	GO:0097169
GeneOntologyCellularComponent	IPAF inflammasome complex	CASP1 CARD16	2.46e-04	4	135	2	GO:0072557
GeneOntologyCellularComponent	pigment granule membrane	TYR TYRP1 GPNMB	3.71e-04	22	135	3	GO:0090741
GeneOntologyCellularComponent	chitosome	TYR TYRP1 GPNMB	3.71e-04	22	135	3	GO:0045009
GeneOntologyCellularComponent	melanosome membrane	TYR TYRP1 GPNMB	3.71e-04	22	135	3	GO:0033162
GeneOntologyCellularComponent	receptor complex	IL11RA TRAV8-1 PDGFRB TRGV1 TRGV4 CUBN ITGAX GDNF CRLF2 PLXNC1 FGFR2 FCRL5	3.94e-04	581	135	12	GO:0043235
GeneOntologyCellularComponent	GATOR1 complex	NPRL3 DEPDC5	4.09e-04	5	135	2	GO:1990130
GeneOntologyCellularComponent	external side of plasma membrane	IL11RA ROBO4 TRGV1 TRGV4 CUBN ITGAX CRLF2 CFHR4 THY1 PLPPR4 FCRL5	5.58e-04	519	135	11	GO:0009897
GeneOntologyCellularComponent	cell body	ADCY10 PCSK2 KLHL24 SNPH ABL1 PGR CFHR4 NSMF THY1 PTPRF GNB5 TRPV2 BRINP2 MAPK8IP2 SEZ6L	9.91e-04	929	135	15	GO:0044297
GeneOntologyCellularComponent	growth cone	ADCY10 SETX ABL1 THY1 PTPRF TRPV2 TRPV4	1.08e-03	245	135	7	GO:0030426
GeneOntologyCellularComponent	protease inhibitor complex	CASP1 CARD16	1.13e-03	8	135	2	GO:0097179
GeneOntologyCellularComponent	NLRP3 inflammasome complex	CASP1 CARD16	1.13e-03	8	135	2	GO:0072559
GeneOntologyCellularComponent	site of polarized growth	ADCY10 SETX ABL1 THY1 PTPRF TRPV2 TRPV4	1.30e-03	253	135	7	GO:0030427
GeneOntologyCellularComponent	peptidase inhibitor complex	CASP1 CARD16	2.19e-03	11	135	2	GO:1904090
Domain	IGc2	ROBO4 MYOM1 PDGFRB ISLR VSIG10 NPTN PTPRF F11R HMCN1 FGFR2 FCRL5	9.01e-07	235	132	11	SM00408
Domain	Ig_sub2	ROBO4 MYOM1 PDGFRB ISLR VSIG10 NPTN PTPRF F11R HMCN1 FGFR2 FCRL5	9.01e-07	235	132	11	IPR003598
Domain	Ig_I-set	ROBO4 MYOM1 PDGFRB ISLR VSIG10 NPTN PTPRF F11R HMCN1 FGFR2	9.99e-07	190	132	10	IPR013098
Domain	I-set	ROBO4 MYOM1 PDGFRB ISLR VSIG10 NPTN PTPRF F11R HMCN1 FGFR2	9.99e-07	190	132	10	PF07679
Domain	ig	IL11RA MYOM1 PDGFRB VSIG10 NPTN THY1 F11R HMCN1 FCRL5	8.35e-06	190	132	9	PF00047
Domain	Immunoglobulin	IL11RA MYOM1 PDGFRB VSIG10 NPTN THY1 F11R HMCN1 FCRL5	8.35e-06	190	132	9	IPR013151
Domain	CUB	TMPRSS15 OVCH2 CUBN C1R SEZ6L	2.43e-05	49	132	5	PF00431
Domain	CUB	TMPRSS15 OVCH2 CUBN C1R SEZ6L	2.68e-05	50	132	5	SM00042
Domain	Sushi	CD46 SVEP1 CFHR4 C1R SEZ6L	3.25e-05	52	132	5	PF00084
Domain	CUB	TMPRSS15 OVCH2 CUBN C1R SEZ6L	3.57e-05	53	132	5	PS01180
Domain	CCP	CD46 SVEP1 CFHR4 C1R SEZ6L	3.91e-05	54	132	5	SM00032
Domain	IG	IL11RA ROBO4 MYOM1 PDGFRB VSIG10 NPTN THY1 PTPRF F11R HMCN1 FGFR2 FCRL5	4.49e-05	421	132	12	SM00409
Domain	Ig_sub	IL11RA ROBO4 MYOM1 PDGFRB VSIG10 NPTN THY1 PTPRF F11R HMCN1 FGFR2 FCRL5	4.49e-05	421	132	12	IPR003599
Domain	IG_LIKE	IL11RA ROBO4 MYOM1 PDGFRB ISLR VSIG10 NPTN THY1 PTPRF F11R HMCN1 FGFR2 FCRL5	4.57e-05	491	132	13	PS50835
Domain	SUSHI	CD46 SVEP1 CFHR4 C1R SEZ6L	4.68e-05	56	132	5	PS50923
Domain	Doc2	DOC2A DOC2B	4.96e-05	2	132	2	IPR014638
Domain	Sushi_SCR_CCP_dom	CD46 SVEP1 CFHR4 C1R SEZ6L	5.10e-05	57	132	5	IPR000436
Domain	CUB_dom	TMPRSS15 OVCH2 CUBN C1R SEZ6L	5.10e-05	57	132	5	IPR000859
Domain	Ig-like_dom	IL11RA ROBO4 MYOM1 PDGFRB ISLR VSIG10 NPTN THY1 PTPRF F11R HMCN1 FGFR2 FCRL5	5.85e-05	503	132	13	IPR007110
Domain	-	IL11RA ROBO4 MYOM1 PDGFRB ISLR VSIG10 CRLF2 NPTN THY1 PTPRF F11R HMCN1 PLXNC1 FGFR2 FCRL5	7.05e-05	663	132	15	2.60.40.10
Domain	CARD	CASP1 CARD16 QRICH1 NOD2	8.32e-05	33	132	4	PS50209
Domain	Ig-like_fold	IL11RA ROBO4 MYOM1 PDGFRB ISLR VSIG10 CRLF2 NPTN THY1 PTPRF F11R HMCN1 PLXNC1 FGFR2 FCRL5	1.41e-04	706	132	15	IPR013783
Domain	-	TYR TYRP1	1.48e-04	3	132	2	1.10.1280.10
Domain	Unchr_di-copper_centre	TYR TYRP1	1.48e-04	3	132	2	IPR008922
Domain	TYROSINASE_1	TYR TYRP1	1.48e-04	3	132	2	PS00497
Domain	TYROSINASE_2	TYR TYRP1	1.48e-04	3	132	2	PS00498
Domain	Tyrosinase	TYR TYRP1	1.48e-04	3	132	2	PF00264
Domain	Tyrosinase_Cu-bd	TYR TYRP1	1.48e-04	3	132	2	IPR002227
Domain	CARD	CASP1 CARD16 NOD2	1.81e-04	16	132	3	SM00114
Domain	TRPV1-4_channel	TRPV2 TRPV4	2.95e-04	4	132	2	IPR008347
Domain	-	TMPRSS15 CUBN C1R SEZ6L	4.96e-04	52	132	4	2.60.120.290
Domain	Tyr_kinase_CSF1/PDGF_rcpt	PDGFRB NPTN	7.30e-04	6	132	2	IPR016243
Domain	CARD	CASP1 CARD16 NOD2	9.93e-04	28	132	3	PF00619
Domain	CARD	CASP1 CARD16 NOD2	1.34e-03	31	132	3	IPR001315
Domain	IGv	VSIG10 THY1 F11R HMCN1	1.97e-03	75	132	4	SM00406
Domain	TRP_channel	TRPV2 TRPV4	2.62e-03	11	132	2	IPR004729
Domain	GFP-like	SVEP1 HMCN1	2.62e-03	11	132	2	IPR023413
Domain	Pentaxin-related	SVEP1 ADGRD2	2.62e-03	11	132	2	IPR001759
Domain	-	SVEP1 HMCN1	2.62e-03	11	132	2	2.40.155.10
Domain	Pentaxin	SVEP1 ADGRD2	2.62e-03	11	132	2	PF00354
Domain	PP2C_BS	PPM1E PPM1L	3.12e-03	12	132	2	IPR000222
Domain	EGF_CA	CUBN SVEP1 HMCN1 C1R	3.24e-03	86	132	4	PF07645
Domain	PP2C_SIG	PPM1E PPM1L	4.27e-03	14	132	2	SM00331
Domain	P_typ_ATPase_c	ATP8B1 ATP11C	4.27e-03	14	132	2	IPR032630
Domain	P-type_ATPase_N	ATP8B1 ATP11C	4.27e-03	14	132	2	IPR032631
Domain	P-type_ATPase_IV	ATP8B1 ATP11C	4.27e-03	14	132	2	IPR006539
Domain	PLAC	ADAMTS6 ADAMTSL2	4.27e-03	14	132	2	PF08686
Domain	PhoLip_ATPase_C	ATP8B1 ATP11C	4.27e-03	14	132	2	PF16212
Domain	PhoLip_ATPase_N	ATP8B1 ATP11C	4.27e-03	14	132	2	PF16209
Domain	-	CASP1 CARD16 QRICH1 NOD2	4.28e-03	93	132	4	1.10.533.10
Domain	PPM_1	PPM1E PPM1L	4.90e-03	15	132	2	PS01032
Domain	EGF_Ca-bd_CS	CUBN SVEP1 HMCN1 C1R	4.98e-03	97	132	4	IPR018097
Domain	WD40_repeat_dom	WDR4 UBR4 DDB1 ZNF106 NBEAL2 GNB5 WDR62	5.21e-03	297	132	7	IPR017986
Domain	DEATH-like_dom	CASP1 CARD16 QRICH1 NOD2	5.35e-03	99	132	4	IPR011029
Domain	EGF_CA	CUBN SVEP1 HMCN1 C1R	5.35e-03	99	132	4	PS01187
Domain	VWF_A	ITGAX SVEP1 BABAM1 HMCN1	5.35e-03	99	132	4	IPR002035
Domain	ASX_HYDROXYL	CUBN SVEP1 HMCN1 C1R	5.54e-03	100	132	4	PS00010
Domain	PP2C	PPM1E PPM1L	6.29e-03	17	132	2	IPR015655
Domain	EGF-type_Asp/Asn_hydroxyl_site	CUBN SVEP1 HMCN1 C1R	6.80e-03	106	132	4	IPR000152
Domain	-	ADCY10 NPR2	7.04e-03	18	132	2	3.30.70.1230
Domain	Nucleotide_cyclase	ADCY10 NPR2	7.04e-03	18	132	2	IPR029787
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	AKAP6 CASP8AP2 SETX PHF12 ECPAS NPLOC4 PLPPR4 ZNF608 ARHGAP31 NBEAL2 PCNX1 DEPDC5 NUP188 RAI1	2.82e-08	529	138	14	14621295
Pubmed	Genetic context determines susceptibility to intraocular pressure elevation in a mouse pigmentary glaucoma.	TYR TYRP1 GPNMB	6.11e-08	3	138	3	16827931
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	DOC2A DOCK3 RAPGEF6 ABL1 UBE4B PHF12 UBR4 RAPGEF1 NOD2 PTPRF NBEAL2 TMCC2 NPRL3 PCNX1 DEPDC5 RIC8A FGFR2 NUP188 RAI1	8.52e-08	1105	138	19	35748872
Pubmed	Prediction of the coding sequences of unidentified human genes. XIII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	DNAJC16 ZBTB1 NAV3 PCNX1 KDM2A SEZ6L	3.45e-06	102	138	6	10231032
Pubmed	Functional proteomics mapping of a human signaling pathway.	UBR4 QRICH1 DDB1 SVEP1 NEDD4 PIGQ ZNF106 PTPRF SECISBP2 KDM2A GPNMB RUBCN	4.53e-06	591	138	12	15231748
Pubmed	Genetic linkage analysis and homology relationships of genes located on human chromosome 11q.	PGR TYR THY1	7.19e-06	10	138	3	1679745
Pubmed	JAM-A associates with ZO-2, afadin, and PDZ-GEF1 to activate Rap2c and regulate epithelial barrier function.	RAPGEF6 F11R TJP2	7.19e-06	10	138	3	23885123
Pubmed	Parvalbumin expression changes with retinal ganglion cell degeneration.	TYRP1 GPNMB	1.56e-05	2	138	2	37901418
Pubmed	The monoclonal antibodies TMH-1 and TMH-2 specifically bind to a protein encoded at the murine b-locus, not to the authentic tyrosinase encoded at the c-locus.	TYR TYRP1	1.56e-05	2	138	2	1706745
Pubmed	GATOR1-related focal cortical dysplasia in epilepsy surgery patients and their families: A possible gradient in severity?	NPRL3 DEPDC5	1.56e-05	2	138	2	33461085
Pubmed	Regulation of tyrosinase processing and trafficking by organellar pH and by proteasome activity.	TYR TYRP1	1.56e-05	2	138	2	14634018
Pubmed	Absence of glaucoma in DBA/2J mice homozygous for wild-type versions of Gpnmb and Tyrp1.	TYRP1 GPNMB	1.56e-05	2	138	2	17608931
Pubmed	Involvement of inflammation, degradation, and apoptosis in a mouse model of glaucoma.	TYRP1 GPNMB	1.56e-05	2	138	2	15985430
Pubmed	Loss of outer retinal neurons and circuitry alterations in the DBA/2J mouse.	TYRP1 GPNMB	1.56e-05	2	138	2	25118265
Pubmed	Doc2b synchronizes secretion from chromaffin cells by stimulating fast and inhibiting sustained release.	DOC2A DOC2B	1.56e-05	2	138	2	24133251
Pubmed	Ethnic variation in tyrosinase and TYRP1 expression in photoexposed and photoprotected human skin.	TYR TYRP1	1.56e-05	2	138	2	12519123
Pubmed	Doc2: a novel brain protein having two repeated C2-like domains.	DOC2A DOC2B	1.56e-05	2	138	2	7826360
Pubmed	Functional TRPV2 and TRPV4 channels in human cardiac c-kit(+) progenitor cells.	TRPV2 TRPV4	1.56e-05	2	138	2	26865051
Pubmed	Direct interaction of tyrosinase with Tyrp1 to form heterodimeric complexes in vivo.	TYR TYRP1	1.56e-05	2	138	2	18042623
Pubmed	DOC2A and DOC2B are sensors for neuronal activity with unique calcium-dependent and kinetic properties.	DOC2A DOC2B	1.56e-05	2	138	2	16515538
Pubmed	PDGFRβ and FGFR2 mediate endothelial cell differentiation capability of triple negative breast carcinoma cells.	PDGFRB FGFR2	1.56e-05	2	138	2	24747080
Pubmed	Lysophosphatidylcholine-induced cytotoxicity in osteoblast-like MG-63 cells: involvement of transient receptor potential vanilloid 2 (TRPV2) channels.	TRPV2 TRPV4	1.56e-05	2	138	2	23964684
Pubmed	Retinal ganglion cell degeneration is topological but not cell type specific in DBA/2J mice.	TYRP1 GPNMB	1.56e-05	2	138	2	16247030
Pubmed	Enhanced expression of the PDGFR/Abl signaling pathway in aromatase inhibitor-resistant breast cancer.	ABL1 PDGFRB	1.56e-05	2	138	2	22865780
Pubmed	Early Cytoskeletal Protein Modifications Precede Overt Structural Degeneration in the DBA/2J Mouse Model of Glaucoma.	TYRP1 GPNMB	1.56e-05	2	138	2	27857681
Pubmed	Mouse genetics: a tool to help unlock the mechanisms of glaucoma.	TYRP1 GPNMB	1.56e-05	2	138	2	10604301
Pubmed	Molecular interactions within the melanogenic complex: formation of heterodimers of tyrosinase and TRP1 from B16 mouse melanoma.	TYR TYRP1	1.56e-05	2	138	2	9918801
Pubmed	RNA interference screen identifies Abl kinase and PDGFR signaling in Chlamydia trachomatis entry.	ABL1 PDGFRB	1.56e-05	2	138	2	18369471
Pubmed	F-actin-binding domain of c-Abl regulates localized phosphorylation of C3G: role of C3G in c-Abl-mediated cell death.	ABL1 RAPGEF1	1.56e-05	2	138	2	20581864
Pubmed	Ocular hypertension suppresses homeostatic gene expression in optic nerve head microglia of DBA/2 J mice.	TYRP1 GPNMB	1.56e-05	2	138	2	32450896
Pubmed	Retinal pathology in the PPCD1 mouse.	TYRP1 GPNMB	1.56e-05	2	138	2	28981549
Pubmed	Fibroblast growth factor receptor two (FGFR2) regulates uterine epithelial integrity and fertility in mice.	PGR FGFR2	1.56e-05	2	138	2	24227756
Pubmed	The TYRP1-mediated protection of human tyrosinase activity does not involve stable interactions of tyrosinase domains.	TYR TYRP1	1.56e-05	2	138	2	31077632
Pubmed	Functional analysis of the tyrosinase gene and brown-locus protein gene promoters.	TYR TYRP1	1.56e-05	2	138	2	8433000
Pubmed	Recessive mutation in a standard recombinant-inbred line of mice affects seminal vesicle shape.	TYR FGFR2	1.56e-05	2	138	2	3181757
Pubmed	Molecular framework for response to imatinib mesylate in systemic sclerosis.	ABL1 PDGFRB	1.56e-05	2	138	2	19180499
Pubmed	Genetic modification of glaucoma associated phenotypes between AKXD-28/Ty and DBA/2J mice.	TYRP1 GPNMB	1.56e-05	2	138	2	11178107
Pubmed	Rai1 duplication causes physical and behavioral phenotypes in a mouse model of dup(17)(p11.2p11.2).	TYR RAI1	1.56e-05	2	138	2	17024248
Pubmed	DOC2 isoforms play dual roles in insulin secretion and insulin-stimulated glucose uptake.	DOC2A DOC2B	1.56e-05	2	138	2	25005332
Pubmed	Morphological disruption and visual tuning alterations in the primary visual cortex in glaucoma (DBA/2J) mice.	TYRP1 GPNMB	1.56e-05	2	138	2	37488870
Pubmed	Identification of Diagnostic Variants in FGFR2 and NPR2 Genes in a Chinese Family Affected by Crouzon Syndrome and Acromesomelic Dysplasia, Type Maroteaux.	NPR2 FGFR2	1.56e-05	2	138	2	36322898
Pubmed	Structural and Functional Rescue of Chronic Metabolically Stressed Optic Nerves through Respiration.	TYRP1 GPNMB	1.56e-05	2	138	2	29760184
Pubmed	Morphology of astrocytes in a glaucomatous optic nerve.	TYRP1 GPNMB	1.56e-05	2	138	2	23322566
Pubmed	Molecular cloning of an isoform of Doc2 having two C2-like domains.	DOC2A DOC2B	1.56e-05	2	138	2	8554557
Pubmed	Doc2b Ca2+ binding site mutants enhance synaptic release at rest at the expense of sustained synaptic strength.	DOC2A DOC2B	1.56e-05	2	138	2	31594980
Pubmed	Quantitative correlation of optic nerve pathology with ocular pressure and corneal thickness in the DBA/2 mouse model of glaucoma.	TYRP1 GPNMB	1.56e-05	2	138	2	16505033
Pubmed	The Contribution of Anterior Segment Abnormalities to Changes in Intraocular Pressure in the DBA/2J Mouse Model of Glaucoma: DBA/2J-Gpnmb +/SjJ Mice as Critical Controls.	TYRP1 GPNMB	1.56e-05	2	138	2	35185449
Pubmed	Iris transillumination defect and its gene modulators do not correlate with intraocular pressure in the BXD family of mice.	TYRP1 GPNMB	1.56e-05	2	138	2	27011731
Pubmed	Diagnostic exome sequencing in non-acquired focal epilepsies highlights a major role of GATOR1 complex genes.	NPRL3 DEPDC5	1.56e-05	2	138	2	32086284
Pubmed	Trafficking of Stretch-Regulated TRPV2 and TRPV4 Channels Inferred Through Interactomics.	TRPV2 TRPV4	1.56e-05	2	138	2	31783610
Pubmed	Doc2b is a high-affinity Ca2+ sensor for spontaneous neurotransmitter release.	DOC2A DOC2B	1.56e-05	2	138	2	20150444
Pubmed	Interacting loci cause severe iris atrophy and glaucoma in DBA/2J mice.	TYRP1 GPNMB	1.56e-05	2	138	2	10192392
Pubmed	Microarray analysis of iris gene expression in mice with mutations influencing pigmentation.	TYRP1 GPNMB	1.56e-05	2	138	2	20739468
Pubmed	The progesterone receptor regulates the expression of TRPV4 channel.	PGR TRPV4	1.56e-05	2	138	2	19701771
Pubmed	Comparison of melanoblast expression patterns identifies distinct classes of genes.	TYR TYRP1 GPNMB	2.15e-05	14	138	3	19493314
Pubmed	A ZFYVE21-Rubicon-RNF34 signaling complex promotes endosome-associated inflammasome activity in endothelial cells.	CASP1 CARD16 RUBCN	3.30e-05	16	138	3	37225719
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	AKAP6 CASP8AP2 DNAJC16 ZNF608 TMCC2 PCNX1 KDM2A	3.41e-05	225	138	7	12168954
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	SNPH UBE4B DNAJC16 PPM1E NEDD4 NAV3 BRINP2 RUBCN SEZ6L	3.83e-05	407	138	9	12693553
Pubmed	Characterization of p87C3G, a novel, truncated C3G isoform that is overexpressed in chronic myeloid leukemia and interacts with Bcr-Abl.	ABL1 RAPGEF1	4.68e-05	3	138	2	16443220
Pubmed	Cryo-EM structures of the human GATOR1-Rag-Ragulator complex reveal a spatial-constraint regulated GAP mechanism.	NPRL3 DEPDC5	4.68e-05	3	138	2	35338845
Pubmed	Excitatory and Inhibitory Neurons Utilize Different Ca2+ Sensors and Sources to Regulate Spontaneous Release.	DOC2A DOC2B	4.68e-05	3	138	2	29754754
Pubmed	Estrogen maintains myometrial tumors in a lymphangioleiomyomatosis model.	PGR GPNMB	4.68e-05	3	138	2	26880751
Pubmed	Meox2 Haploinsufficiency Accelerates Axonal Degeneration in DBA/2J Glaucoma.	TYRP1 GPNMB	4.68e-05	3	138	2	31369031
Pubmed	Protein kinase C-beta-mediated complex formation between tyrosinase and TRP-1.	TYR TYRP1	4.68e-05	3	138	2	14623273
Pubmed	Tyrosinase gene family and Vogt-Koyanagi-Harada disease in Japanese patients.	TYR TYRP1	4.68e-05	3	138	2	17200659
Pubmed	Kaliziri extract upregulates tyrosinase, TRP-1, TRP-2 and MITF expression in murine B16 melanoma cells.	TYR TYRP1	4.68e-05	3	138	2	24884952
Pubmed	Anemonin is a natural bioactive compound that can regulate tyrosinase-related proteins and mRNA in human melanocytes.	TYR TYRP1	4.68e-05	3	138	2	17766092
Pubmed	Paneth cells directly sense gut commensals and maintain homeostasis at the intestinal host-microbial interface.	CASP1 NOD2	4.68e-05	3	138	2	19075245
Pubmed	ASIP and TYR pigmentation variants associate with cutaneous melanoma and basal cell carcinoma.	TYR TYRP1	4.68e-05	3	138	2	18488027
Pubmed	Complement peptide C3a receptor 1 promotes optic nerve degeneration in DBA/2J mice.	TYRP1 GPNMB	4.68e-05	3	138	2	33176797
Pubmed	Doc2 is a Ca2+ sensor required for asynchronous neurotransmitter release.	DOC2A DOC2B	4.68e-05	3	138	2	22036572
Pubmed	Genetic, cytogenetic, and molecular analyses of mutations induced by melphalan demonstrate high frequencies of heritable deletions and other rearrangements from exposure of postspermatogonial stages of the mouse.	TYR TYRP1	4.68e-05	3	138	2	1352884
Pubmed	DOC2 proteins in rat brain: complementary distribution and proposed function as vesicular adapter proteins in early stages of secretion.	DOC2A DOC2B	4.68e-05	3	138	2	9115738
Pubmed	Molecular determinants of permeation through the cation channel TRPV4.	TRPV2 TRPV4	4.68e-05	3	138	2	12093812
Pubmed	Retinoic acid controls the homeostasis of pre-cDC-derived splenic and intestinal dendritic cells.	TYRP1 THY1	4.68e-05	3	138	2	23999499
Pubmed	Tyrosinase stabilization by Tyrp1 (the brown locus protein).	TYR TYRP1	4.68e-05	3	138	2	9822646
Pubmed	Molecular genetics of oculocutaneous albinism.	TYR TYRP1	4.68e-05	3	138	2	7849740
Pubmed	High-molecular-weight forms of tyrosinase and the tyrosinase-related proteins: evidence for a melanogenic complex.	TYR TYRP1	4.68e-05	3	138	2	8040609
Pubmed	Disease-linked mutations in Munc18-1 deplete synaptic Doc2.	DOC2A DOC2B	4.68e-05	3	138	2	38242640
Pubmed	Missing optomotor head-turning reflex in the DBA/2J mouse.	TYRP1 GPNMB	4.68e-05	3	138	2	21757588
Pubmed	The landscape of epilepsy-related GATOR1 variants.	NPRL3 DEPDC5	4.68e-05	3	138	2	30093711
Pubmed	Calcium regulation by thermo- and osmosensing transient receptor potential vanilloid channels (TRPVs) in human conjunctival epithelial cells.	TRPV2 TRPV4	4.68e-05	3	138	2	22327830
Pubmed	Involvement of GATOR complex genes in familial focal epilepsies and focal cortical dysplasia.	NPRL3 DEPDC5	4.68e-05	3	138	2	27173016
Pubmed	Cell-specific ATP7A transport sustains copper-dependent tyrosinase activity in melanosomes.	TYR TYRP1	4.68e-05	3	138	2	18650808
Pubmed	Tyrosinase and related proteins in mammalian pigmentation.	TYR TYRP1	4.68e-05	3	138	2	8601447
Pubmed	Recombinant-inbred strains. An aid to finding identity, linkage, and function of histocompatibility and other genes.	TYR TYRP1	4.68e-05	3	138	2	5558564
Pubmed	Combined inhibition of c-Abl and PDGF receptors for prevention and treatment of murine sclerodermatous chronic graft-versus-host disease.	ABL1 PDGFRB	4.68e-05	3	138	2	22940072
Pubmed	NOD2, the gene responsible for familial granulomatous uveitis, in a mouse model of uveitis.	NOD2 TYR	4.68e-05	3	138	2	18385071
Pubmed	Glycoprotein nonmetastatic melanoma protein B regulates lysosomal integrity and lifespan of senescent cells.	TYRP1 GPNMB	4.68e-05	3	138	2	35444208
Pubmed	Thermosensitive transient receptor potential channels in human corneal epithelial cells.	TRPV2 TRPV4	4.68e-05	3	138	2	21506114
Pubmed	Susceptibility to neurodegeneration in a glaucoma is modified by Bax gene dosage.	TYRP1 GPNMB	4.68e-05	3	138	2	16103918
Pubmed	Activation of c-Abl Kinase Potentiates the Anti-myeloma Drug Lenalidomide by Promoting DDA1 Protein Recruitment to the CRL4 Ubiquitin Ligase.	ABL1 DDB1	4.68e-05	3	138	2	28087699
Pubmed	Functional characterization of transient receptor potential channels in mouse urothelial cells.	TRPV2 TRPV4	4.68e-05	3	138	2	20015940
Pubmed	Reverse genetics in the mouse and its application to the study of deafness.	TYR TYRP1	4.68e-05	3	138	2	1952626
Pubmed	Doc2 Proteins Are Not Required for the Increased Spontaneous Release Rate in Synaptotagmin-1-Deficient Neurons.	DOC2A DOC2B	4.68e-05	3	138	2	32098902
Pubmed	Analysis of TRPV channel activation by stimulation of FCεRI and MRGPR receptors in mouse peritoneal mast cells.	TRPV2 TRPV4	4.68e-05	3	138	2	28158279
Pubmed	Seizure features and outcomes in 50 children with GATOR1 variants: A retrospective study, more favorable for epilepsy surgery.	NPRL3 DEPDC5	4.68e-05	3	138	2	37259768
Pubmed	Rapid identification of major-effect genes using the collaborative cross.	TYR TYRP1	4.68e-05	3	138	2	25236450
Pubmed	Evaluation of the effect of narrow band-ultraviolet B on the expression of tyrosinase, TYRP-1, and TYRP-2 mRNA in vitiligo skin and their correlations with clinical improvement: A retrospective study.	TYR TYRP1	4.68e-05	3	138	2	33314655
Pubmed	Age-related accumulation of phosphorylated mitofusin 2 protein in retinal ganglion cells correlates with glaucoma progression.	TYRP1 GPNMB	4.68e-05	3	138	2	28684211
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	ROBO4 MYOM1 PDGFRB ISLR VSIG10 NPTN PTPRF HMCN1 FGFR2	2.06e-07	161	97	9	593
GeneFamily	Hyalectan proteoglycans\|V-set domain containing\|Sushi domain containing\|C-type lectin domain containing	CD46 SVEP1 CFHR4 C1R SEZ6L	1.35e-05	57	97	5	1179
GeneFamily	Complement system\|Sushi domain containing	CD46 ITGAX CFHR4 C1R	4.02e-05	36	97	4	492
GeneFamily	Immunoglobulin like domain containing	IL11RA PDGFRB VSIG10 NPTN THY1 F11R FCRL5	8.09e-05	193	97	7	594
GeneFamily	ADAM metallopeptidase domain containing\|CD molecules	PDGFRB CD46 ITGAX FZD9 THY1 F11R PLXNC1 FGFR2 FCRL5	2.67e-04	394	97	9	471
GeneFamily	WD repeat domain containing\|Caspase recruitment domain containing\|Apoptosome	CASP1 CARD16 NOD2	5.47e-04	30	97	3	959
GeneFamily	Synaptotagmin like tandem C2 proteins	DOC2A DOC2B	1.25e-03	10	97	2	822
GeneFamily	ATPase phospholipid transporting	ATP8B1 ATP11C	2.86e-03	15	97	2	1210
GeneFamily	Protein phosphatases, Mg2+/Mn2+ dependent	PPM1E PPM1L	3.68e-03	17	97	2	701
Coexpression	HE_LIM_SUN_FETAL_LUNG_C0_MID_AIRWAY_SMC_1_CELL	KIF26B TYRP1 PLPPR4 ADAMTS6 MTARC1 ADAMTSL2	1.90e-06	71	136	6	M45677
CoexpressionAtlas	JC_fibro_top-relative-expression-ranked_500_k-means-cluster#3	PDGFRB KIF26B ATP8B1 ISLR SVEP1 PLPPR4 NAV3 C1R GPNMB	3.95e-06	206	126	9	JC_fibro_500_K3
CoexpressionAtlas	JC_fibro_top-relative-expression-ranked_2500_k-means-cluster#5	NPR2 SNPH RAPGEF6 OVCH2 PDGFRB KIF26B ATP8B1 ISLR SVEP1 SLC35F5 THY1 PLPPR4 NAV3 C1R GPNMB MAPK8IP2	2.61e-05	814	126	16	JC_fibro_2500_K5
CoexpressionAtlas	JC_fibro_top-relative-expression-ranked_500	AKAP6 OVCH2 PDGFRB KIF26B ATP8B1 ISLR SVEP1 THY1 PLPPR4 NAV3 C1R GPNMB	3.89e-05	494	126	12	JC_fibro_500
ToppCell	TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_NOS-3\|TCGA-Stomach / Sample_Type by Project: Shred V9	PDGFRB ISLR SVEP1 THY1 HMCN1 PLPPR4 ARHGAP31 NAV3 C1R	1.02e-08	194	138	9	2260cd817a6661e5eb6645b0c6786e18fd58371e
ToppCell	facs-Trachea-nan-18m-Myeloid-lymphocyte_of_B_lineage\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DOCK3 OVCH2 CRLF2 LAX1 MOCS3 SECISBP2 KDM2A FCRL5	3.85e-08	160	138	8	5c9281706009558c8361bfa76169f43ffc0f7947
ToppCell	facs-Trachea-18m-Hematologic-lymphocytic-B_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	DOCK3 OVCH2 CRLF2 LAX1 SECISBP2 KDM2A RP2 FCRL5	4.66e-08	164	138	8	4274a4f225cabf61f0fe27d8ea162b4eba612f87
ToppCell	facs-Trachea-18m-Hematologic-lymphocytic-B_cell-B_cell_of_the_trachea\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	DOCK3 OVCH2 CRLF2 LAX1 SECISBP2 KDM2A RP2 FCRL5	4.66e-08	164	138	8	d62143450f59097ad4b34603a6257f897a769ead
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PDGFRB SVEP1 PGR ZNF106 HMCN1 PLPPR4 NAV3 C1R	1.91e-07	197	138	8	94a9603cbd3516fbcce871909693b88f20d41713
ToppCell	saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic-Classical_Monocyte-Mono_c3-CD14-VCAN\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	DOC2A FUZ CARD16 PPEF2 ARHGAP31 MAPK8IP2	6.62e-07	99	138	6	a815a887094204de30b299e8907e81ad9a39c016
ToppCell	NS-moderate-d_16-33-Lymphoid-NK\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	PDGFRB ISLR TYR TYRP1 THY1 NAV3 C1R	1.64e-06	182	138	7	fb503f8ecd013f1f2161a5841572b57cfcddb6fa
ToppCell	(2)_Fibroblasts-(20)_Fibro-1\|(2)_Fibroblasts / Cell class and subclass of bone marrow stroma cells in homeostatis	IL11RA ATP8B1 ISLR SVEP1 THY1 HMCN1 GPNMB	1.89e-06	186	138	7	e93415b59dd89bc8a966dab0e0b65fe215933598
ToppCell	TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_Carcinoma-6\|TCGA-Breast / Sample_Type by Project: Shred V9	PDGFRB KIF26B PGR THY1 HMCN1 ADAMTS6 PLXNC1	1.96e-06	187	138	7	a96495803ba13fcfadd1d83b3cf5774f3fed0a20
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PDGFRB ISLR PGR THY1 HMCN1 PLPPR4 C1R	2.26e-06	191	138	7	0fae1c2ef9f83ac7721d0a9d69455bf97eed9257
ToppCell	nucseq-Mesenchymal-Myocytic-Myocytic_2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	PDGFRB KIF26B ISLR THY1 HMCN1 NAV3 C1R	2.42e-06	193	138	7	5de87fc94a6e58899ef4124cf4887ed3ff96163a
ToppCell	3'-GW_trimst-1-SmallIntestine-Neuronal-neurons_A-Branch_A3_(IPAN/IN)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	AKAP6 DOCK3 TMEM145 TRPV2 MAPK8IP2 SEZ6L DOC2B	2.59e-06	195	138	7	5a6a5048af638872700b76b7c71a8fa3fb8d3772
ToppCell	15-Trachea-Mesenchymal-Mesenchyme_SERPINF1-high\|Trachea / Age, Tissue, Lineage and Cell class	IL11RA PDGFRB ISLR SVEP1 THY1 C1R GPNMB	2.68e-06	196	138	7	54aefcebf13704f51de84379e2e22ec0734b9461
ToppCell	Biopsy_Control_(H.)-Mesenchymal-Myofibroblasts\|Biopsy_Control_(H.) / Sample group, Lineage and Cell type	PDGFRB ISLR SVEP1 THY1 HMCN1 PLPPR4 C1R	2.96e-06	199	138	7	7a227c239afdaebcac84644d9b2653a5f1a4be71
ToppCell	Biopsy_Other_PF-Mesenchymal-Myofibroblasts\|Biopsy_Other_PF / Sample group, Lineage and Cell type	PDGFRB ISLR SVEP1 THY1 HMCN1 PLPPR4 C1R	3.06e-06	200	138	7	e504570fd7eec1524c401b1cfa9d10822d80d994
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	ROBO4 SETX SLF1 NEDD4 HMCN1 ZNF608 DOC2B	3.06e-06	200	138	7	dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell	5'-Adult-Distal_Rectal-Mesenchymal\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ABL1 PDGFRB ISLR SVEP1 THY1 C1R GPNMB	3.06e-06	200	138	7	db6281b5d4032116310db379d9175d790994c99c
ToppCell	5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ABL1 PDGFRB ISLR SVEP1 THY1 C1R GPNMB	3.06e-06	200	138	7	10f0c20ba7c71d9e2e177597f85b41cb40f0d878
ToppCell	5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ABL1 PDGFRB ISLR SVEP1 THY1 C1R GPNMB	3.06e-06	200	138	7	a2bb67a06757f19be3f56f8cb5bb7e2affa5f4ed
ToppCell	(5)_Fibroblast-E\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	PDGFRB ISLR SVEP1 THY1 NAV3 C1R GPNMB	3.06e-06	200	138	7	75e5ecb05e965e24d569aa2ef5cdf740b1528c06
ToppCell	Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_myofibroblast\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	PDGFRB ISLR SVEP1 THY1 HMCN1 PLPPR4 C1R	3.06e-06	200	138	7	54806080b5e97859ee6a4a9b4f19e22021c218f5
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-1m-Mesenchymal-BMP_responsible_cell\|1m / Sample Type, Dataset, Time_group, and Cell type.	PDGFRB SLC35F5 TYRP1 C1R ATP11C FGFR2 GPNMB	3.06e-06	200	138	7	06d615fe4b7dd5128dbdcd510a5ff3eb480c61b2
ToppCell	Biopsy_IPF-Mesenchymal-Myofibroblasts\|Biopsy_IPF / Sample group, Lineage and Cell type	PDGFRB ISLR TYRP1 THY1 HMCN1 PLPPR4 C1R	3.06e-06	200	138	7	c2c6f687c49ba790174b27c7b8b084af30b34c86
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-6m-Mesenchymal\|6m / Sample Type, Dataset, Time_group, and Cell type.	MYOM1 KLHL31 TYR TYRP1 LRRIQ1 TRPV4 GPNMB	3.06e-06	200	138	7	13ec8afea86e4a10599c924871ba4e325b0a8013
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MYOM1 PDGFRB SLFN14 ADAMTS6 ATP11C ADGRD2	1.11e-05	161	138	6	1b805f77790aeb8a71b08bfac2fe2eed7343258f
ToppCell	droplet-Liver-LIVER_HEP-30m-Myeloid-macrophage/monocyte\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DOC2A ITGAX CRLF2 KLHL31 FCRL5 GPNMB	1.15e-05	162	138	6	93bd29c52846c3156b8b0d2e39c552373efdfe93
ToppCell	droplet-Marrow-nan-3m-Myeloid-basophil\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DNAJC16 FUZ RAPGEF1 NOD2 ARHGAP31 KIAA1328	1.47e-05	169	138	6	5f5bec13208f4c3b6eacbba180c8a6402743b76e
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MYOM1 PDGFRB SLFN14 ADAMTS6 ATP11C ADGRD2	1.62e-05	172	138	6	08a3fe536b1b064c5ee7779bc2b1115a5963a26b
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MYOM1 PDGFRB SLFN14 ADAMTS6 ATP11C ADGRD2	1.62e-05	172	138	6	553701349444eb366df3c11f54bb093434f153c6
ToppCell	10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_cytotoxic-D\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	IL11RA PHF12 NBPF20 NBEAL2 ATP11C HSF2	1.79e-05	175	138	6	a3f8c54c77bce9b035a4835945ab341909be4946
ToppCell	droplet-Heart-nan-3m\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AKAP6 RBM20 NEDD4 ZNF106 HMCN1 ADAMTSL2	1.84e-05	176	138	6	749b47eac5436fa34e0d243ffbc6f1897f4e431e
ToppCell	356C-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)\|356C / Donor, Lineage, Cell class and subclass (all cells)	PDGFRB ISLR TYRP1 THY1 C1R ADAMTSL2	1.84e-05	176	138	6	135d51d28a7ad2a67d5a6c49eb6e661f4beb66f5
ToppCell	356C-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)-\|356C / Donor, Lineage, Cell class and subclass (all cells)	PDGFRB ISLR TYRP1 THY1 C1R ADAMTSL2	1.84e-05	176	138	6	2287bd8382f41e36ebb0875a0133bada1ec81fa7
ToppCell	356C-Fibroblasts-Fibroblast-C_(Myofibroblast)-\|356C / Donor, Lineage, Cell class and subclass (all cells)	PDGFRB KIF26B PPM1E SVEP1 PGR THY1	1.90e-05	177	138	6	cdfd2f0ee2f692271b1525e414b0f645cdadb1f6
ToppCell	356C-Fibroblasts-Fibroblast-C_(Myofibroblast)\|356C / Donor, Lineage, Cell class and subclass (all cells)	PDGFRB KIF26B PPM1E SVEP1 PGR THY1	1.90e-05	177	138	6	db222faaecbe5600da39277243c4e7e764eb63c9
ToppCell	-Donor_02\|World / lung cells shred on cell class, cell subclass, sample id	PDGFRB ISLR SVEP1 PGR NAV3 ADAMTSL2	2.03e-05	179	138	6	10fadbaa1b6d21cbf9f354d717cc4c225619f4fd
ToppCell	5'-Airway_Nasal-Mesenchymal-Fibroblastic\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PDGFRB KIF26B ISLR THY1 HMCN1 PLPPR4	2.09e-05	180	138	6	935c091bbcd6d10b81dc4731779e5bd98205c99f
ToppCell	5'-Airway_Nasal-Mesenchymal\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PDGFRB KIF26B ISLR THY1 HMCN1 PLPPR4	2.09e-05	180	138	6	3dd384b7f3d9582b8fec9fe05100e466e6218b76
ToppCell	critical-Lymphoid-NK\|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	PCSK2 ROBO4 TYR TYRP1 PLPPR4 NAV3	2.09e-05	180	138	6	5abf778395392244daaec876f306ed7e4f388686
ToppCell	wk_15-18-Mesenchymal-Chondrocyte\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	GDNF FZD9 TYRP1 TMEM145 TRPV4 FGFR2	2.16e-05	181	138	6	8950844b3e65c7028d80da5787ae2ce509c3d52d
ToppCell	metastatic_Brain-Fibroblasts-Myofibroblasts\|metastatic_Brain / Location, Cell class and cell subclass	ISLR SVEP1 THY1 HMCN1 PLPPR4 C1R	2.16e-05	181	138	6	bd0b5f74f9c81ec0f1592710774a4fdf33d9d5a9
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PDGFRB ISLR SVEP1 HMCN1 NAV3 C1R	2.23e-05	182	138	6	3dfa9187e9d2bab1d199079d29209c4648220ada
ToppCell	droplet-Heart-nan-3m-Endothelial-endothelial_cell_of_coronary_artery\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ROBO4 F11R ZNF608 SACS ARHGAP31 NAV3	2.23e-05	182	138	6	81279877b920b5a1bc991a07d3031d6458700fe3
ToppCell	NS-critical-d_07-13-Lymphoid-NK\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	PCSK2 ROBO4 TYR TYRP1 PLPPR4 NAV3	2.23e-05	182	138	6	dd1c59babf7211362452e3e264009d70004d99f6
ToppCell	facs-Heart-LA-3m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AKAP6 MYOM1 PDGFRB THY1 PPM1L BRINP2	2.30e-05	183	138	6	8d45dff06a199b1369576657f7f9dc0249c5f841
ToppCell	5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PDGFRB KIF26B ISLR THY1 HMCN1 PLPPR4	2.30e-05	183	138	6	803376f5260de83c48d4f7301278d078a32b3e6e
ToppCell	5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PDGFRB KIF26B ISLR THY1 HMCN1 PLPPR4	2.30e-05	183	138	6	6d98973098c6d20c5305bce6a83a549a7d8dbfba
ToppCell	5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PDGFRB KIF26B ISLR THY1 HMCN1 PLPPR4	2.30e-05	183	138	6	cc7f5a17b40e8d901885174922e5fa8877643071
ToppCell	facs-Heart-LA-3m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AKAP6 MYOM1 PDGFRB THY1 PPM1L BRINP2	2.30e-05	183	138	6	421265fa15d5a028cb567bb0904e670473ef102b
ToppCell	5'-GW_trimst-2-LymphNode-Mesenchymal-fibroblastic-Stromal_3_(C7+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IL11RA ISLR THY1 PLPPR4 NAV3 C1R	2.37e-05	184	138	6	4d4d8f3f44c67d74c57e7af7b7c158f0157b2f49
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PDGFRB KIF26B ISLR THY1 HMCN1 C1R	2.44e-05	185	138	6	87c416d14ca6255bee39b16e7571553e36ee3069
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PDGFRB ISLR SVEP1 HMCN1 PLPPR4 C1R	2.52e-05	186	138	6	5473283fb95cee556b1f6934cf72169b676b5bcc
ToppCell	facs-Limb_Muscle-Muscle_forelimb_and_hindlimb-18m-Mesenchymal-mesenchymal_stem_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IL11RA PDGFRB ISLR SVEP1 THY1 GPNMB	2.52e-05	186	138	6	a7ab70b049742dfe7ee30557031bfac6412edf52
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	KIF26B TYRP1 PLPPR4 ADAMTS6 MTARC1 ADAMTSL2	2.59e-05	187	138	6	387cb27c8a20031cd87381a9e1172f1f62e1488b
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ADARB2-AS1 CUBN SVEP1 ATP11C SEZ6L DOC2B	2.59e-05	187	138	6	d2ffb2f34f07b0dd5d3cb3ee0275f46ebecf4146
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6-Inh_L1_PAX6_CA4\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ADARB2-AS1 CUBN SVEP1 ATP11C SEZ6L DOC2B	2.67e-05	188	138	6	ee572246e0c2f41bdbc29a03edc67b831af95c09
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	KIF26B TYRP1 PLPPR4 ADAMTS6 PLXNC1 ADAMTSL2	2.67e-05	188	138	6	3004e961d214919e08c7cd5f10c3de5cf85b35a3
ToppCell	5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic-Stromal_3_(C7+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ABL1 PDGFRB ISLR SVEP1 THY1 C1R	2.75e-05	189	138	6	f7d57723b8fb0f1e1485f51e3eff93ec0f39761e
ToppCell	RV-04._Ventricular_Cardiomyocyte_I\|RV / Chamber and Cluster_Paper	AKAP6 DOCK3 KLHL24 MYOM1 RBM20 KLHL31	2.75e-05	189	138	6	9c1debd65c13d63fd4f3158917d621b44b714c26
ToppCell	Control-B_intermediate-6\|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5)	UBR4 ITGAX SACS PLXNC1 IQSEC1 FCRL5	2.75e-05	189	138	6	11cb9a16f1de8f60af2073ed7ea6d4f41c02f299
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	KIF26B TYRP1 PLPPR4 ADAMTS6 MTARC1 ADAMTSL2	2.75e-05	189	138	6	0abc7a4900cc9033bc1be69b770ccc54a6bf41b4
ToppCell	LPS_only-Endothelial-Endothelial-Alv_Cap\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SLF1 NEDD4 ZNF608 ARHGAP31 PPM1L ZC3H12C	2.84e-05	190	138	6	474cbbab8f3b0a6881fa6c92edb78e43999f9ab0
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Endothelial-Alv_Gen_Intermediate\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ROBO4 SLF1 NEDD4 ARHGAP31 PPM1L ZC3H12C	2.84e-05	190	138	6	a3c6eec6df052105ab78b7e3c78f94218d5912eb
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PDGFRB KIF26B SVEP1 PGR C1R ADAMTSL2	2.92e-05	191	138	6	a58c75e9580139fb370b498d95660f10f3a2a27b
ToppCell	facs-Heart-LV-3m-Mesenchymal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDGFRB ATP8B1 ISLR SVEP1 NEDD4 THY1	2.92e-05	191	138	6	b7a57691a4742070cee640e285c1f4d0da95baf1
ToppCell	LPS_only-Endothelial-Endothelial-Activated_Alv_Cap\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ROBO4 SLF1 NEDD4 ZNF608 ARHGAP31 ZC3H12C	2.92e-05	191	138	6	a7b18bcf27c38ad2353c239ecb309c80f3ef3359
ToppCell	facs-Trachea-nan-18m-Mesenchymal-fibroblast\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IL11RA PDGFRB ISLR SVEP1 NEDD4 GPNMB	2.92e-05	191	138	6	783e8c436de90623bb1bc4117270d60c8c8a9461
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	IL11RA PCSK2 KIF26B ISLR THY1 NAV3	2.92e-05	191	138	6	156b467187331ac6ca390d6ca861d9670bb7b956
ToppCell	metastatic_Lymph_Node-Fibroblasts-Myofibroblasts\|metastatic_Lymph_Node / Location, Cell class and cell subclass	PDGFRB ISLR THY1 HMCN1 C1R ADAMTSL2	2.92e-05	191	138	6	aa43b472bc8362f79ae63f09f1ca764718bbf22c
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PDGFRB KIF26B SVEP1 PGR C1R ADAMTSL2	3.01e-05	192	138	6	9093a9e94a25682d109a7f6edc256a25a61103a0
ToppCell	facs-Trachea-nan-18m-Mesenchymal-nan\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IL11RA PDGFRB ISLR SVEP1 NEDD4 GPNMB	3.01e-05	192	138	6	f388a336062880609724e91bf51bd0f9c4da2f69
ToppCell	nucseq-Mesenchymal-Myocytic-Myocytic_2-SCMF\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	PDGFRB KIF26B ISLR THY1 HMCN1 NAV3	3.01e-05	192	138	6	67e845e513e76e820f55e2f0d15eb16f2944d05c
ToppCell	LV-04._Ventricular_Cardiomyocyte_I\|LV / Chamber and Cluster_Paper	AKAP6 DOCK3 KLHL24 MYOM1 RBM20 KLHL31	3.01e-05	192	138	6	ad19e2c1d36a0566c9b12ced10db78f4781c8ea6
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PDGFRB KIF26B SVEP1 PGR C1R ADAMTSL2	3.01e-05	192	138	6	9ed5d49621ec1aa01716dc369bba1450b5f015f5
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	KLHL24 OVCH2 VSIG10 ZNF608 NBEAL2 FGFR2	3.01e-05	192	138	6	29f49f00770c991b5f27e4cb701dd2d2d6cb7178
ToppCell	facs-Trachea-nan-18m-Mesenchymal\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IL11RA PDGFRB ISLR SVEP1 NEDD4 GPNMB	3.01e-05	192	138	6	ceadfbce037bef15523916ba091bb6c0d752cce5
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PDGFRB ISLR PGR THY1 PLPPR4 C1R	3.01e-05	192	138	6	b9e4585bea280ca0ae159f0c6a2bf7b88a15a6e6
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	PDGFRB ISLR SVEP1 THY1 NAV3 C1R	3.01e-05	192	138	6	e0f4e4470a71bfa81d9dcd8594e5f82aafc24f81
ToppCell	10x5'v1-week_12-13-Mesenchymal_adipo-stroma\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	PDGFRB ISLR SVEP1 THY1 HMCN1 C1R	3.10e-05	193	138	6	cf2461af78f65616ce40d552ee9452295e3895ed
ToppCell	LPS-antiTNF-Endothelial-Endothelial-Gen_Cap\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SLF1 ATP8B1 HMCN1 ZNF608 ADAMTS6 ARHGAP31	3.10e-05	193	138	6	6e1982d089a9de628e6006d23ff78a223fbd9f47
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_myocytic\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	DOCK3 KIF26B TYRP1 THY1 PLPPR4 ADAMTSL2	3.10e-05	193	138	6	000b9e6a819b94ea2e6e9173daf97ba9ac2b6cc6
ToppCell	10x5'v1-week_12-13-Mesenchymal_adipo\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	PDGFRB ISLR SVEP1 THY1 HMCN1 C1R	3.10e-05	193	138	6	6ef9007c9d18fb775d08fb20cdf954a28d54d7eb
ToppCell	10x5'v1-week_12-13-Mesenchymal_adipo-stroma-adipo-CAR\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	PDGFRB ISLR SVEP1 THY1 HMCN1 C1R	3.10e-05	193	138	6	e4ea7ce011a80b81b841c907719aa532bed39d2e
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SLF1 ATP8B1 HMCN1 ZNF608 ADAMTS6 ARHGAP31	3.19e-05	194	138	6	0b9cd96fa0b616da7cc90e92ff71157e9bba518f
ToppCell	368C-Fibroblasts-Fibroblast-G-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	CARD16 CD46 SVEP1 TYRP1 F11R HMCN1	3.19e-05	194	138	6	d9eec28fa7b255c0ec023276dd955f1e276e7159
ToppCell	Control-Stromal-Myofibroblast\|World / Disease state, Lineage and Cell class	PDGFRB ISLR SVEP1 HMCN1 C1R ADAMTSL2	3.19e-05	194	138	6	3c2266772c5b56e8e02a461e5193e29588028ee9
ToppCell	LPS_only-Endothelial\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ROBO4 SLF1 ATP8B1 NEDD4 ZNF608 ARHGAP31	3.19e-05	194	138	6	58f069efdefa0366033764446b9d6ffd4a17807e
ToppCell	LPS_only-Endothelial-Endothelial\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ROBO4 SLF1 ATP8B1 NEDD4 ZNF608 ARHGAP31	3.19e-05	194	138	6	bfd92ec75facb0ba55c31e5f2e089d983b3d0169
ToppCell	368C-Fibroblasts-Fibroblast-G\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	CARD16 CD46 SVEP1 TYRP1 F11R HMCN1	3.19e-05	194	138	6	e4d7e9709ce42d4610e44d3445927eefbcbb9eff
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_myocytic\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	KIF26B TYRP1 THY1 PLPPR4 ADAMTS6 ADAMTSL2	3.19e-05	194	138	6	67f5e2f05a8de2213ab80d5ea16fdee121684633
ToppCell	Control-Stromal-Myofibroblast\|Control / Disease state, Lineage and Cell class	PDGFRB ISLR SVEP1 HMCN1 C1R ADAMTSL2	3.28e-05	195	138	6	ffcf76cd72e43d8cf1058a49c76e0956065038bc
ToppCell	LPS_only-Endothelial-Endothelial-Activated_Gen_Cap\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ROBO4 SLF1 ATP8B1 NEDD4 ZNF608 ARHGAP31	3.28e-05	195	138	6	56efeb58df19f357d7d5ce87348d4f196a595421
ToppCell	ASK428-Mesenchymal\|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq	PDGFRB ISLR THY1 PLPPR4 NAV3 C1R	3.28e-05	195	138	6	2b156163975d9a3d3fda1402acd9831d0fdc9e25
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PDGFRB ISLR SVEP1 HMCN1 C1R ADAMTSL2	3.28e-05	195	138	6	df409f94f4e83be89f7a608058ee07ce3ce3a149
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PDGFRB ISLR SVEP1 HMCN1 C1R ADAMTSL2	3.28e-05	195	138	6	4243190ad291d56694e2155954dbaa879c9d3844
ToppCell	ASK428-Mesenchymal-Fibroblast\|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq	PDGFRB ISLR THY1 PLPPR4 NAV3 C1R	3.28e-05	195	138	6	c269c0d894a0f55da6495b59d4b9abb9f68df684
ToppCell	facs-Lung-3m\|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NPR2 NPTN PTPRF IQSEC1 FGFR2 HSF2	3.28e-05	195	138	6	c4648c0332c3826776f9ad3f5f803dbac2b4c0c0
ToppCell	15-Trachea-Mesenchymal\|Trachea / Age, Tissue, Lineage and Cell class	IL11RA PDGFRB ISLR SVEP1 THY1 C1R	3.38e-05	196	138	6	7e178c76285e61c721c38d7a995ebf89dc428f9f
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	PDGFRB ISLR SVEP1 THY1 NAV3 C1R	3.38e-05	196	138	6	525d6c8a277364e624e7cc586275f8a891436b57
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PDGFRB KIF26B SVEP1 PGR C1R ADAMTSL2	3.38e-05	196	138	6	a12dd986df65c36f248cf10815c3b8b6238613b0
Drug	M-IBDET	ABL1 CASP1 CARD16 PGR	7.88e-08	8	134	4	CID005464042
Drug	AC1NUKW9	ABL1 CASP1 CARD16	7.94e-07	4	134	3	CID005481610
Drug	Gabazine [105538-73-6]; Up 200; 10.8uM; HL60; HT_HG-U133A	IL11RA UBR4 FUZ MOCS3 IQSEC1 NAV3 NPRL3 PCNX1 DEPDC5	2.29e-06	194	134	9	1316_UP
Drug	(+,-)-Synephrine [94-07-5]; Down 200; 24uM; MCF7; HT_HG-U133A	KLHL24 NPR2 WDR4 ECPAS ZBTB1 F11R NBEAL2 PCNX1 FGFR2	2.71e-06	198	134	9	3578_DN
Drug	nitrofuran	NPR2 FUZ SECISBP2 MAPK8IP2	1.32e-05	25	134	4	CID000011865
Drug	Flupentixol dihydrochloride cis-(Z) [2413-38-9]; Up 200; 7.8uM; MCF7; HT_HG-U133A	PDGFRB CASP1 ZBTB1 SLC35F5 NOD2 TYRP1 THY1 FGFR2	2.08e-05	195	134	8	2643_UP
Drug	Canavanine sulfate monohydrate (L,+) [206996-57-8]; Down 200; 13.6uM; MCF7; HT_HG-U133A	SETX PPM1E CD46 ZBTB1 SACS GNB5 RP2 FGFR2	2.16e-05	196	134	8	4782_DN
Drug	Tomatidine [77-59-8]; Up 200; 9.6uM; MCF7; HT_HG-U133A	KLHL24 DNAJC16 CASP1 ECPAS PIGQ PLXNC1 TMCC2 SEZ6L	2.24e-05	197	134	8	2746_UP
Drug	Cortisone [53-06-5]; Down 200; 11uM; MCF7; HT_HG-U133A	WDR4 UBE4B FUZ NBEAL2 IQSEC1 SECISBP2 KDM2A RUBCN	2.32e-05	198	134	8	7416_DN
Drug	haloperidol; Up 200; 10uM; HL60; HT_HG-U133A	AKAP6 WDR4 PPM1E ZBTB1 NOD2 IQSEC1 NUP188 SEZ6L	2.32e-05	198	134	8	6163_UP
Drug	Tetracycline hydrochloride [64-75-5]; Up 200; 8.4uM; HL60; HG-U133A	WDR4 DNAJC16 CUBN PIGQ F11R NPRL3 SEZ6L PUS7L	2.50e-05	200	134	8	1397_UP
Drug	Diphenyl Ether Sulfonamide 10	CASP1 CARD16	3.44e-05	2	134	2	CID009887536
Drug	Diphenyl Ether Sulfonamide 2	CASP1 CARD16	3.44e-05	2	134	2	CID015888281
Drug	Diphenyl Ether Sulfonamide 9	CASP1 CARD16	3.44e-05	2	134	2	CID015888283
Drug	Diphenyl Ether Sulfonamide 5	CASP1 CARD16	3.44e-05	2	134	2	CID015888282
Drug	arylsulfonamide analogue 16	CASP1 CARD16	3.44e-05	2	134	2	CID015888284
Drug	Diphenyl Ether Sulfonamide 7	CASP1 CARD16	3.44e-05	2	134	2	CID015888286
Drug	arylsulfonamide analogue 11	CASP1 CARD16	3.44e-05	2	134	2	CID015888279
Drug	Diphenyl Ether Sulfonamide 12	CASP1 CARD16	3.44e-05	2	134	2	CID010070710
Drug	AC1NR9V6	CASP1 CARD16	3.44e-05	2	134	2	CID005287535
Drug	AAF-cmk	CASP1 CARD16	3.44e-05	2	134	2	CID006610326
Drug	AC1NRAF8	CASP1 CARD16	3.44e-05	2	134	2	CID005287849
Drug	1rww	CASP1 CARD16	3.44e-05	2	134	2	CID005289080
Drug	Biphenyl Sulfonamide 1	CASP1 CARD16	3.44e-05	2	134	2	CID010449481
Drug	1rwx	CASP1 CARD16	3.44e-05	2	134	2	CID005289610
Drug	Cyclo(lys-pro)	CASP1 CARD16	3.44e-05	2	134	2	CID000194922
Drug	AC1L1B6T	CASP1 CARD16 TYR TYRP1	7.25e-05	38	134	4	CID000001308
Drug	AC1NBJ9O	CASP1 CARD16	1.03e-04	3	134	2	CID004468934
Drug	afzelin	TYR TYRP1	1.03e-04	3	134	2	ctd:C477954
Drug	AC1MU7EP	TRPV2 TRPV4	1.03e-04	3	134	2	CID003661571
Drug	Dabcyl-ice-edans	CASP1 CARD16	1.03e-04	3	134	2	CID005748518
Drug	Isothiuronium	TYR TYRP1	1.03e-04	3	134	2	ctd:D007550
Drug	bepl	CASP8AP2 MARS1	1.03e-04	3	134	2	CID000131659
Drug	AC1NBK95	ABL1 PGR THY1	1.06e-04	16	134	3	CID004469365
Drug	2-propylpentanoic acid; Down 200; 500uM; MCF7; HT_HG-U133A	KLHL24 NPR2 B3GNTL1 ATP8B1 MOCS3 BRINP2 PCNX1	1.36e-04	190	134	7	5237_DN
Drug	wortmannin from Penicillium funiculosum; Up 200; 0.01uM; MCF7; HT_HG-U133A	KLHL24 CASP1 FUZ ANKRA2 PCNX1 RP2 WDR62	1.40e-04	191	134	7	6959_UP
Drug	D90A	SETX PDGFRB CASP1 CARD16 GDNF	1.47e-04	85	134	5	CID000023715
Drug	Epitiostanol [2363-58-8]; Up 200; 13uM; MCF7; HT_HG-U133A	ROBO4 DNAJC16 SLC35F5 FZD9 THY1 BRINP2 PUS7L	1.49e-04	193	134	7	4788_UP
Drug	AC1L1B45	MARS1 CASP1 CARD16	1.52e-04	18	134	3	CID000001275
Drug	MGA-100	CUBN PGR NPRL3	1.52e-04	18	134	3	CID000018020
Drug	Palmatine chloride [3486-67-7]; Up 200; 10.4uM; MCF7; HT_HG-U133A	DOC2A DNAJC16 FUZ SVEP1 PLXNC1 BRINP2 MAPK8IP2	1.59e-04	195	134	7	2795_UP
Drug	(1-[(4-Chlorophenyl)phenyl-methyl]-4-methylpiperazine) [1620-21-9]; Down 200; 11.8uM; MCF7; HT_HG-U133A	TMPRSS15 B3GNTL1 WDR4 PLXNC1 PCNX1 DEPDC5 FGFR2	1.59e-04	195	134	7	3893_DN
Drug	Ioversol [87771-40-2]; Down 200; 5uM; MCF7; HT_HG-U133A	SETX SCYL3 CD46 ZBTB1 GNB5 KDM2A RP2	1.64e-04	196	134	7	5326_DN
Drug	AG-013608 [351320-38-2]; Up 200; 10uM; PC3; HT_HG-U133A	KLHL24 NPR2 WDR4 MARS1 CASP1 TRPV4 NUP188	1.70e-04	197	134	7	5949_UP
Drug	estradiol; Up 200; 0.01uM; PC3; HT_HG-U133A	IL11RA TMPRSS15 CASP1 SVEP1 SLC35F5 PLXNC1 TRPV4	1.70e-04	197	134	7	5960_UP
Drug	Mimosine [500-44-7]; Down 200; 20.2uM; MCF7; HT_HG-U133A	DOC2A KLHL24 CASP1 NSMF F11R NBEAL2 IQSEC1	1.70e-04	197	134	7	2638_DN
Drug	Vancomycin hydrochloride [1404-93-9]; Up 200; 2.6uM; PC3; HT_HG-U133A	NPR2 TMPRSS15 SVEP1 PLXNC1 DEPDC5 GPNMB WDR62	1.70e-04	197	134	7	4598_UP
Drug	Propafenone hydrochloride [34183-22-7]; Down 200; 10.6uM; HL60; HG-U133A	KLHL24 MARS1 CASP1 ANKRA2 NPRL3 TJP2 RUBCN	1.75e-04	198	134	7	1722_DN
Drug	2-propylpentanoic acid; Down 200; 1000uM; MCF7; HT_HG-U133A	KLHL24 NPR2 UBE4B FUZ CD46 IQSEC1 HSF2	1.75e-04	198	134	7	6929_DN
Drug	Captopril [62571-86-2]; Up 200; 17.2uM; PC3; HG-U133A	ROBO4 KLHL24 WDR4 DNAJC16 CASP1 PTPRF RP2	1.75e-04	198	134	7	1907_UP
Drug	Bromopride [4093-35-0]; Up 200; 11.6uM; HL60; HT_HG-U133A	TMPRSS15 KIF26B PTPRF IQSEC1 NUP188 MTARC1 SEZ6L	1.75e-04	198	134	7	2182_UP
Drug	Novobiocin sodium salt [1476-53-5]; Up 200; 6.4uM; MCF7; HT_HG-U133A	IL11RA SVEP1 TMCC2 TRPV2 DEPDC5 FGFR2 NUP188	1.75e-04	198	134	7	4392_UP
Drug	Chlortetracycline hydrochloride [64-72-2]; Up 200; 7.8uM; HL60; HG-U133A	ROBO4 ATP8B1 NEDD4 F11R TMCC2 FGFR2 WDR62	1.75e-04	198	134	7	2042_UP
Drug	Protoveratrine A [143-57-7]; Down 200; 5uM; PC3; HT_HG-U133A	IL11RA WDR4 MARS1 PTPRF PCNX1 GPNMB WDR62	1.81e-04	199	134	7	6618_DN
Drug	Retrorsine [480-54-6]; Up 200; 11.4uM; MCF7; HT_HG-U133A	CASP1 ECPAS ANKRA2 TMCC2 PCNX1 NUP188 SEZ6L	1.81e-04	199	134	7	4946_UP
Drug	Beta-sistosterol [83-46-5]; Up 200; 9.6uM; HL60; HT_HG-U133A	UBR4 ZBTB1 SVEP1 PIGQ PTPRF NUP188 MTARC1	1.86e-04	200	134	7	2912_UP
Drug	Lomefloxacin hydrochloride [98079-52-8]; Up 200; 10.4uM; HL60; HT_HG-U133A	NPR2 WDR4 SVEP1 THY1 MOCS3 TRPV2 PUS7L	1.86e-04	200	134	7	2348_UP
Drug	(R)-(+)-Atenolol [56715-13-0]; Down 200; 15uM; MCF7; HT_HG-U133A	SETX MARS1 FUZ ATP8B1 IQSEC1 PCNX1 FGFR2	1.86e-04	200	134	7	4841_DN
Drug	ecgonine methyl ester	AKAP6 NPR2 PGR NPRL3 SCP2	2.03e-04	91	134	5	CID000104904
Drug	AC1L2365	PDGFRB TYR	2.05e-04	4	134	2	CID000014121
Drug	norgestomet	PGR FGFR2	2.05e-04	4	134	2	ctd:C100284
Drug	AC1L1FCE	TMPRSS15 FGFR2	2.05e-04	4	134	2	CID000003176
Drug	AC1ODTZD	CASP1 CARD16	2.05e-04	4	134	2	CID007020821
Drug	lamtidine	TYR TYRP1	2.05e-04	4	134	2	CID000071988
Drug	sweroside	TYR TYRP1	2.05e-04	4	134	2	ctd:C049412
Drug	pyrrole-2,3,5-tricarboxylic acid	TYR TYRP1	2.05e-04	4	134	2	ctd:C071226
Drug	cinchomeronate	CASP1 CARD16	2.05e-04	4	134	2	CID000010273
Disease	Familial focal epilepsy with variable foci	NPRL3 DEPDC5	5.76e-05	3	130	2	cv:C1858477
Disease	Epilepsy, Partial, with Variable Foci	NPRL3 DEPDC5	5.76e-05	3	130	2	C1858477
Disease	oculocutaneous albinism (is_implicated_in)	TYR TYRP1	1.15e-04	4	130	2	DOID:0050632 (is_implicated_in)
Disease	focal epilepsy (is_implicated_in)	NPRL3 DEPDC5	1.15e-04	4	130	2	DOID:2234 (is_implicated_in)
Disease	meningococcal meningitis (is_implicated_in)	CD46 NOD2	1.15e-04	4	130	2	DOID:0080176 (is_implicated_in)
Disease	Intellectual Disability	AKAP6 WDR4 PDGFRB QRICH1 SACS IQSEC1 FGFR2 WDR62 RAI1	1.70e-04	447	130	9	C3714756
Disease	Malignant neoplasm of breast	AKAP6 ABL1 STXBP4 UBR4 PPM1E ATP8B1 CUBN PGR NEDD4 SCP2 RIC8A FGFR2 FCRL5 GPNMB	2.85e-04	1074	130	14	C0006142
Disease	Colorectal Carcinoma	AKAP6 PCSK2 PPM1E CD46 ISLR CUBN SACS GNB5 ATP11C KDM2A GPNMB	2.87e-04	702	130	11	C0009402
Disease	optic disc size measurement	RAPGEF1 NPLOC4 TYR LRRIQ1 NAV3 HSF2	3.05e-04	205	130	6	EFO_0004832
Disease	Albinism, Oculocutaneous	TYR TYRP1	3.99e-04	7	130	2	C0078918
Disease	Oculocutaneous albinism	TYR TYRP1	3.99e-04	7	130	2	cv:C0078918
Disease	Intrahepatic Cholestasis	ATP8B1 TJP2	3.99e-04	7	130	2	C0008372
Disease	Complement deficiency disease	CD46 CFHR4 C1R	4.14e-04	33	130	3	C0272242
Disease	Growth Disorders	SECISBP2 RAI1 ADAMTSL2	5.36e-04	36	130	3	C0018273
Disease	Atypical hemolytic-uremic syndrome	CD46 CFHR4	6.80e-04	9	130	2	cv:C2931788
Disease	Hemolytic-uremic syndrome	CD46 CFHR4	6.80e-04	9	130	2	cv:C0019061
Disease	nevus count, cutaneous melanoma	RAPGEF1 TYR TYRP1 TMCC2	7.15e-04	91	130	4	EFO_0000389, EFO_0004632
Disease	melanoma	ABL1 UBR4 CUBN TYR TYRP1 RAI1	8.31e-04	248	130	6	C0025202
Disease	cerebrospinal fluid biomarker measurement	PDGFRB PPEF2 C1R GPNMB	8.74e-04	96	130	4	EFO_0006794
Disease	pigmentation disease (is_implicated_in)	TYR TYRP1	1.03e-03	11	130	2	DOID:10123 (is_implicated_in)
Disease	Charcot-Marie-Tooth Disease	SETX TRPV4	1.24e-03	12	130	2	C0007959
Disease	Neurobehavioral Manifestations	UBE4B RAI1	1.24e-03	12	130	2	C0525041
Disease	renal sinus adipose tissue measurement	TJP2 FCRL5	1.46e-03	13	130	2	EFO_0004864
Disease	tyrosine-protein kinase receptor Tie-1, soluble measurement	NPRL3 ADAMTSL2	1.46e-03	13	130	2	EFO_0008312
Disease	endometrial carcinoma	CASP8AP2 KIF26B PLPPR4 NAV3	1.60e-03	113	130	4	EFO_1001512
Disease	brain connectivity measurement	SLF1 KIF26B QRICH1 GDNF NEDD4 LRRIQ1 NAV3	2.03e-03	400	130	7	EFO_0005210
Disease	cutaneous melanoma	RAPGEF1 TYR TYRP1 TMCC2	2.05e-03	121	130	4	EFO_0000389
Disease	retinal vasculature measurement	PDGFRB NPLOC4 ZNF106 GNB5 IQSEC1 NAV3 TJP2 FGFR2	2.12e-03	517	130	8	EFO_0010554
Disease	Spondyloepiphyseal Dysplasia	TRPV4 ADAMTSL2	2.22e-03	16	130	2	C0038015
Disease	Spondyloepiphyseal Dysplasia Tarda, X-Linked	TRPV4 ADAMTSL2	2.22e-03	16	130	2	C3541456
Disease	Schwartz-Jampel Syndrome, Type 1	TRPV4 ADAMTSL2	2.22e-03	16	130	2	C4551479
Disease	Abnormal behavior	IQSEC1 TRPV4	2.22e-03	16	130	2	C0233514
Disease	Schwartz-Jampel Syndrome	TRPV4 ADAMTSL2	2.22e-03	16	130	2	C0036391
Disease	Melnick-Needles Syndrome	TRPV4 ADAMTSL2	2.22e-03	16	130	2	C0025237
Disease	Van Buchem disease	TRPV4 ADAMTSL2	2.51e-03	17	130	2	C0432272
Disease	Charcot-Marie-Tooth disease type 2	MARS1 TRPV4	2.51e-03	17	130	2	cv:C0270914
Disease	drug-Induced dyskinesia, response to levodopa	LRPPRC LINC01549	2.81e-03	18	130	2	EFO_0010747, EFO_1000904
Disease	Abnormality of refraction	AKAP6 DOCK3 NPLOC4 NEDD4 TDRD7 TYRP1 PTPRF ZNF608 TJP2	3.03e-03	673	130	9	HP_0000539
Disease	Osteochondrodysplasias	TRPV4 ADAMTSL2	3.14e-03	19	130	2	C0029422
Disease	unipolar depression, response to bupropion, mood disorder	ADAMTS6 NAV3	3.14e-03	19	130	2	EFO_0003761, EFO_0004247, EFO_0006326
Disease	Dyschondroplasias	TRPV4 ADAMTSL2	3.14e-03	19	130	2	C0013366
Disease	Multiple Epiphyseal Dysplasia	TRPV4 ADAMTSL2	3.47e-03	20	130	2	C0026760
Disease	serum alanine aminotransferase measurement, response to combination chemotherapy	PDCD2 CFHR4 DEPDC5	3.84e-03	71	130	3	EFO_0004735, EFO_0007965
Disease	photoreceptor cell layer thickness measurement	NPLOC4 CFHR4 TYR FGFR2	4.23e-03	148	130	4	EFO_0803370

Protein segments in the cluster

Peptide	Gene	Start	Entry
SGTYCVNLTLGDDTS	GPNMB	461	Q14956
LTTALSLEAYAADTC	ADARB2-AS1	101	A8MUL3
FVSSELEGACSEYLA	NPR2	66	P20594
ESALSLACSKGYTDI	ANKRA2	216	Q9H9E1
SCISKELDSYLGEGS	ADCY10	716	Q96PN6
DIYAGLDSAVSDSAS	CASP8AP2	31	Q9UKL3
AECSSELYTEASGYI	C1R	191	P00736
NSLCYVETAELDGET	ATP8B1	221	O43520
LSYTGQASSDCLETV	ADAMTS6	1046	Q9UKP5
EAEEEYSSLCELLGS	RAI1	866	Q7Z5J4
AESETGLSLEDSDCY	RBM20	1011	Q5T481
CIYTDSTEVAGSLLE	QRICH1	61	Q2TAL8
FASGSDDATCRLYDL	GNB5	296	O14775
SYFGASLCSVDVDSD	ITGAX	456	P20702
CEYTALISVSGSDIL	OR5D14	181	Q8NGL3
LDQYICSAGSEDFSL	DEPDC5	921	O75140
DSGLYACTASRTVDS	FGFR2	101	P21802
STDEGTYICQTLDGA	IL11RA	86	Q14626
NGLSCISSELTDASY	KLHL31	41	Q9H511
YLDGSDTIVCDSNST	CD46	261	P15529
SLTCDGDTLTLSAAY	MTARC1	116	Q5VT66
DASFTCILKDGIYSS	NEDD4	111	P46934
CEITTYRSLLESSDG	KRT39	391	Q6A163
SLGIVSFLCSEDASY	DHRS4L1	251	P0CG22
SFLCSEDASYLTGET	DHRS4L1	256	P0CG22
TLSRACLDDSYASGE	IQSEC1	901	Q6DN90
SEDLECYSSTAPVSE	KIF26B	1236	Q2KJY2
ALDDISLTYGICNGS	TMPRSS15	491	P98073
DLSEITDDCGLGLSY	MAPK8IP2	36	Q13387
QGLSTYKELCSLASD	ECPAS	1061	Q5VYK3
EEGTYSCLATNELGS	ISLR	321	O14498
FSSVSVGDQDDCYSL	FAM199X	86	Q6PEV8
STGDCFILASDYLNA	PCNX1	1581	Q96RV3
AESCSLGTGYTEEFV	PDCD2	321	Q16342
SGSCLDQLDYSLEHS	PLXNC1	61	O60486
SLTTEHSGIYSCEAD	FCRL5	716	Q96RD9
DSSFDLYDDSQLCGS	NAV3	1506	Q8IVL0
LYDDSQLCGSATSLE	NAV3	1511	Q8IVL0
YSGAITAHCSLDLLD	LINC01549	31	A6NIU2
ARDLKEAYDSLCTSG	NPRL3	201	Q12980
KDTYFLSSEECITAG	NPLOC4	331	Q8TAT6
EAIGSCSDVDSSLYL	DNAJC16	721	Q9Y2G8
CSDVDSSLYLGESRG	DNAJC16	726	Q9Y2G8
CTSLYSPGAEDSDSL	LAX1	241	Q8IWV1
GFDSSVYSDLCEAAE	ADAMTSL2	656	Q86TH1
GDLSTALEVAIDCYE	LRPPRC	836	P42704
LSLVSNGCYEGSLSE	NSMF	71	Q6X4W1
SGSCDAAETTYDKIL	GDNF	146	P39905
QDAVTVTCSDLSYGD	CRLF2	131	Q9HC73
QCSSVELDGSYLSIA	KIAA1328	201	Q86T90
EDTDILSCSYGAVSN	LRRIQ1	76	Q96JM4
LSDEGFYECIAVSSA	HMCN1	491	Q96RW7
YICGDADSASTVLDG	PPM1E	411	Q8WY54
ADSASTVLDGTEDYL	PPM1E	416	Q8WY54
ALETLSSAEVCAGIY	SCYL3	91	Q8IZE3
ASSSGSTLECILYKA	PGR	451	P06401
TACLQDYTDDLGTFT	CUBN	1046	O60494
GDELTGLCYVASTDA	FZD9	381	O00144
ISDLSINSLYCLSDE	KDM2A	1141	Q9Y2K7
GEATDTILCYDPATS	KLHL24	556	Q6TFL4
YDLETASCSTFNLEG	BABAM1	171	Q9NWV8
ICEEDSYLAGTLGLS	CASP1	76	P29466
GTLEFDLLYDRASCT	DOC2A	91	Q14183
ADGYESDDCTALGTL	DOC2B	116	Q14184
SDDCTALGTLDFSLL	DOC2B	121	Q14184
CTAEITGEYVSCLLS	DOCK3	936	Q8IZD9
GLSSSSSCYLEEALQ	ABL1	16	P00519
ESSYGNTTDSIVCGE	CFHR4	181	Q92496
LDYCRTSVSALSGAT	EMC6	26	Q9BV81
SYLSEQDFGSCADLE	RUBCN	476	Q92622
TADIYSLVDEFSLCG	SACS	1666	Q9NZJ4
ICEEDSYLAETLGLS	CARD16	76	Q5EG05
GETSIAECLTYLDNG	DDB1	306	Q16531
VTDLLDYEAFCGSSA	MOCS3	306	O95396
SYCLIDSFLGDSELI	FUZ	131	Q9BT04
AELEDSGTYTCNVTE	PDGFRB	281	P09619
VSTCYSEEITVCGDL	PPEF2	166	O14830
DEAIYECTATNSLGE	PTPRF	101	P10586
ASLVSEESSISYGGC	OR13A1	101	Q8NGR1
LTEAEASEATLFYLC	HSF2	506	Q03933
PLSASDTGEYSCEAR	F11R	201	Q9Y624
EGSSLLTCYSRETGT	SEZ6L	841	Q9BYH1
TLALFSETAYEEATC	SLFN14	761	P0C7P3
LTGASDTYSLCEVSV	RAPGEF6	786	Q8TEU7
ADAEGYFAACTTDTT	SLC35F5	141	Q8WV83
TLVSSPKYGSDDECS	TMCC2	466	O75069
SAEITCDLPGASTLY	TRGV1	36	A0A0A0MS02
DSLDRSYSTPSGCLE	NBPF20	3191	P0DPF2
SACLLASSESDDSLY	PWWP3B	151	Q5H9M0
ICSISAVDGLDYEAA	PWWP3B	646	Q5H9M0
SLLISFDLDASCYAT	PUS7L	676	Q9H0K6
SLEIEESGDCTSDYV	OVCH2	476	Q7RTZ1
DTCGIYLISGSRDTT	NBEAL2	2511	Q6ZNJ1
VDSCSYDLDQLFIGT	PIGQ	436	Q9BRB3
ISDGCRYLLSSDSQE	PRAMEF22	241	A3QJZ6
GTTVDNVLYSCDFSE	PHF12	861	Q96QT6
LEKLTVSYDEAGTTC	PPM1L	181	Q5SGD2
SDRSDYNCTGGTEVL	SETX	1391	Q7Z333
YSGCTLELEESLEAS	SECISBP2	831	Q96T21
LASLSDVCSIDYISG	TDRD7	381	Q8NHU6
DALEASSLLSSGVDC	SNPH	256	O15079
DCFSTNELLTYEALG	SCP2	306	P22307
ENLSCTSLIEASGEY	STXBP4	116	Q6ZWJ1
LTCLEGYDFTEGSTD	SVEP1	751	Q4LDE5
ALACYADISVSEGSV	RIC8A	91	Q9NPQ8
DGQALSTDLGVYTCE	ROBO4	101	Q8WZ75
ALSYITCSSEGELVC	BRINP2	276	Q9C0B6
VAQSSGSYLCFLDSD	B3GNTL1	101	Q67FW5
LSLDCGITAFELSDY	AKAP6	216	Q13023
TTGCSVAALYLDSTA	ADGRD2	616	Q7Z7M1
DLILLSSCTTDGTCY	ATP11C	161	Q8NB49
DGTCYVTTASLDGES	ATP11C	171	Q8NB49
LTSEEIGSFECSGYV	NKAPL	326	Q5M9Q1
SYIVEDICSGSDLTV	PLPPR4	226	Q7Z2D5
DSLEDYDTLGTLCNS	TYRP1	291	P17643
YLSCDSRLISDFEDT	TJP2	911	Q9UDY2
FLSTYDGAETLCLED	NOD2	236	Q9HC29
SEGLAEYCTLIDSSS	RAPGEF1	951	Q13905
GLALAAKECSLDSDY	UBE4B	526	O95155
LTLEDSGTYECRASN	NPTN	106	Q9Y639
SSDESCLVVLFAGDY	RP2	231	O75695
YDLASVDSCEENSVL	TRPV2	341	Q9Y5S1
ADVEFCLSLTQYESG	TYR	316	P14679
LSAFTSKDEGTYTCA	THY1	91	P04216
VAETEGSSCTSLLEY	NUP188	1086	Q5SRE5
SAEITCDLAEGSTGY	TRGV4	36	A0A0C4DH28
DGIEGYDILVACSSS	TAAR2	186	Q9P1P5
ASAFGCDLTEYLESS	ARHGAP31	16	Q2M1Z3
SDDLGSYVSLSCDDF	SLF1	646	Q9BQI6
ESLTSYGLECSSFQD	ZNF582	106	Q96NG8
CGLTITEEDLSSHYL	ZBTB1	426	Q9Y2K1
SCSDKSISVIDFYSG	WDR62	691	O43379
ALECSEPSTSVSAYD	ZNF608	606	Q9ULD9
ESLSLGDEGIYTCQE	VSIG10	91	Q8N0Z9
SIASSDDDSLFIYDC	WDR4	26	P57081
DYRISSVASDCSSEG	ZC3H12C	616	Q9C0D7
ILSEAASLELGCNYS	TRAV8-1	31	A0A0A6YYK1
LTSYLDELSIAGECA	UBR4	4166	Q5T4S7
LYLCGTDEYGTATET	MARS1	306	P56192
SSLYDLSSLDTCGEE	TRPV4	416	Q9HBA0
GCDEVSSTSEIGTRY	ZNF106	1471	Q9H2Y7
VVSEEGTRYLSCSSG	TMEM145	121	Q8NBT3
ESGLDSAEASTYEVL	NAALADL1	91	Q9UQQ1
GIYSCDVTDTDGIAS	MYOM1	1206	P52179
NDGRTALYDESCSST	PCSK2	336	P16519